Quarterly report pursuant to Section 13 or 15(d)

Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details)

v3.22.2
Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details) - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Securities borrowed or purchased under agreements to resell    
Gross Assets/Liabilities $ 533,938 $ 527,054
Amounts Offset (261,508) (276,334)
Net Balance Sheet Amount 272,430 250,720
Financial Instruments (242,902) (229,525)
Net Assets/Liabilities 29,528 21,195
Securities loaned or sold under agreements to repurchase    
Gross Liabilities 465,815 468,663
Amounts Offset (261,508) (276,334)
Net Balance Sheet Amount 204,307 192,329
Financial Instruments (194,375) (181,860)
Net Liabilities 9,932 10,469
Other    
Gross Liabilities 6,761 11,391
Amounts Offset 0 0
Net Balance Sheet Amount 6,761 11,391
Financial Instruments (6,761) (11,391)
Net Liabilities 0 0
Total Securities Financing Agreements Liability    
Gross Liabilities 472,576 480,054
Amounts Offset (261,508) (276,334)
Net Balance Sheet Amount 211,068 203,720
Financial Instruments (201,136) (193,251)
Net Liabilities 9,932 10,469
Loans and leases repurchase activity $ 11,700 $ 20,100